# Azithromycin+Amoxicillin/Clavulanate vs Amoxicillin/Clavulanate in COVID19 Patients With Pneumonia in Non-intensive Unit

> **NCT04363060** · PHASE3 · UNKNOWN · sponsor: **Nantes University Hospital** · enrollment: 104 (estimated)

## Conditions studied

- COVID-19 Pneumonia

## Interventions

- **COMBINATION_PRODUCT:** Azithromycin with amoxicillin/clavulanate
- **DRUG:** amoxicillin/clavulanate

## Key facts

- **NCT ID:** NCT04363060
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-30
- **Primary completion:** 2020-07-30
- **Final completion:** 2020-07-30
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2020-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04363060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04363060, "Azithromycin+Amoxicillin/Clavulanate vs Amoxicillin/Clavulanate in COVID19 Patients With Pneumonia in Non-intensive Unit". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04363060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*